key: cord-0858201-mx85wijb authors: Möckel, Martin; Bolanaki, Myrto; Hofmann, Jörg; Stein, Angela; Hitzek, Jennifer; Holert, Fabian; Fischer-Rosinský, Antje; Slagman, Anna title: SARS-CoV-2 screening in patients in need of urgent inpatient treatment in the Emergency Department (ED) by digitally integrated point-of-care PCR: A clinical cohort study date: 2022-01-16 journal: Diagn Microbiol Infect Dis DOI: 10.1016/j.diagmicrobio.2022.115637 sha: be789958ae21ce32cfab54dc7aa6304ae939ebea doc_id: 858201 cord_uid: mx85wijb Patients in need of urgent inpatient treatment were recruited prospectively. A rapid point of care PCR test (POC-PCR; Liat®) for SARS-CoV2 was conducted in the ED and a second PCR-test from the same swab was ordered in the central laboratory (CL-PCR). POC-PCR analyzers were digitally integrated in the laboratory information system. Overall, 160 ED patients were included. A valid POC-PCR-test result was available in 96.3% (n=154) of patients. N=16 patients tested positive for SARS-CoV-2 (10.0%). The POC PCR test results were available within 102 minutes (median, IQR: 56-211), which was significantly earlier compared to the CL PCR (811 minutes; IQR: 533-1289, p < 0.001). The diagnostic accuracy of the POC- PCR test was 100%. The implementation and digital LIS integration was successfully done. Staff satisfaction with the POC process was high. The POC-PCR testing in the emergency department is feasible and shows a very high diagnostic performance. Trial registration: DRKS00019207 The COVID-19 pandemic put major challenges on Emergency Departments (ED) worldwide(1). One major aspect was that all urgent patients had to be treated mostly without knowing the SARS-CoV-2 status as laboratory based polymerase chain reaction (PCR)-test usually took at least 6-8 hours of turn-around-time (TAT) (2) . The introduction of rapid antigen testing had the advantage of faster results on the cost of false negative results. Although some authors thought that false negative rapid antigen tests may due to low virus concentrations only(3), we could show that this is not true in clinical practice and that among false negatives are infectious patients with high virus load (4) . Thus, specifically for emergencies, which require immediate intervention or operation and probably airwaymanagement like patients with multiple trauma, acute myocardial infarction or stroke, a rapid, point-of-care (POC) SARS-CoV-2 PCR test would be of utmost importance (5) . POC testing is standard in the ED for clinical chemistry parameters like lactate, electrolytes or cardiac troponin. For molecular diagnostics there have been first attempts with influenza POC testing (6) . Due to the high importance of the test results, which touch regulatory aspects like hygiene rules and due the fast disposition and transfers (i.e. operating theatre, ICU) of the high urgent patients, a digital integration of the POC device in the LIS seems mandatory. In addition, strict testing rules to guarantee correct results, staff safety and reliable results information for all involved health care professionals have to be applied. Finally, the used instrument and assay need to provide reliable results under routine conditions (7) . Therefore, in the current study, a SARS-CoV-2 PCR POC analyzer was digitally integrated in the LIS and tests were run by ED staff in high urgent patients. All inpatients are screened for SARS-CoV-2 in our ED. Consecutive patients were prospectively recruited once it became clear that an acute intervention of any kind was indicated. Clinical characteristics and in-hospital follow-up information of all included patients were extracted from electronic medical records. The primary endpoint of the analyses was turn-around-time (TAT) of the POC-PCR as compared to TAT of the CL-PCR in relation to the first intervention. Secondary endpoints were diagnostic performance, staff satisfaction with test handling and transfer of test results, patient safety and description of further clinical endpoints (e.g. stay on the intensive care unit (ICU), extra-corporal membrane oxygenation (ECMO), in-hospital mortality). Descriptive analyses included the calculation of relative and absolute frequencies as well as median and interquartile range (IQR). Statistical differences were calculated using the Chisquare test for categorical variables and the Mann-Whitney test for continuous variables. A p-value of less than 0.05 was considered statistically significant. Due to the exploratory nature of the analysis, no corrections were made for multiple testing. Liat®POC analyzers (Roche Molecular Systems) were connected to the laboratory information system via the hospital LAN system and Roche infinity POC middleware. The POC test was ordered via the laboratory channel, a barcode was generated and put on the test tube. A triple test cartridge (SARS-CoV-2, influenza A & B) was used. The barcode was scanned by the POC instrument and identified the order. Once the analyzer completed the test run, results were automatically transferred. In the central (molecular biology) laboratory the POC test results were automatically confirmed and transferred to the hospital information system. The LIS-HIS interface was refreshed every 15min. Thus with a 20min testing time on the Liat® analyzers, the SARS-CoV-2 POC test results were digitally available hospital wide within a maximum of 35min after the start of test. As the work with potential contagious samples require specific hygiene rules, these were set up according to national regulations. One challenge was that these rules allow the SARS-CoV-2 sample handling outside a laboratory setting only, if it is performed by the protected person who did the swab. Therefore, we set up the procedure in the way that the POC test cartridge was filled from the primary tube in the isolation room of the patient. Once the cartridge was closed, no further sample contact could occur and it could be handled by another member of the staff, who started the test run of the instrument at a central location of the ED under standard hygiene conditions. The details of the POC test procedure are available in the supplemental material (S1). The primary tube was immediately sent to the central laboratory and 1000µL were used for measurement on a Cobas 6800 instrument for confirmation of the POC test results. For standardization purposes defined virus preparations and dilutions were measured. Transport media were prepared and provided by the institute of virology and directly pipetted into the test cartridge without further dilution in a buffer in our research laboratory. The digitally integrated use of the POC instrument in the ED is summarized in the figure 1. The Ethics committee of the Charité approved the study as an amendment to a previous POC influenza investigation (EA2/204/19). The study was registered in the German Clinical Trials Registry (DRKS00019207). The population of patients in urgent need of inpatient treatment (n=160) consisted of 10.0% of patients tested positive for SARS-CoV-2 in POC-PCR-testing (n=16) and 86.3% who were tested negative (86.3%). In 6 patients an invalid result occurred. Figure 2 shows the patient flow diagram. Of all patient, 43.1% (n=69) were women and the median age was 68 years (IQR: 51-78). In confirmed SARS-CoV-2 cases by POC-PCR-testing, the proportion of female patients was 50.0% (n=8) as compared to 41.3% (n=57) in patients who were tested negative for SARS-CoV-2 (table 1a) . The most common symptoms in SARS-CoV-2 positive cases were Dyspnea The POC PCR test was available within 102 minutes (median, IQR: 56-211) after admission, which was significantly earlier compared to the CL PCR (811 min; IQR: 533-1289, p < 0.001). In 77.4% of patients the first relevant intervention depending on the inclusion criteria (acute severe trauma, stroke, myocardial infarction, operation, intervention needed within 6 hours after presentation, ICU admission needed within 6 hours after presentation) was done within 6 hours (n=113). The POC test result was available before the intervention in 92.1% (n=129) compared to 5.4% test results from the CL (n=8). There were no positive influenza tests. We measured standard samples provided by the institute of virology. The supplement table shows results of calibration samples measurements Ct-values were converted into estimated virus concentrations per mL buffer using the standards listed in the supplement table. Levels below 10 6 per mL buffer are considered as "weak positive", between 10 6 and 10 7 are considered as "intermediate" and over 10 7 as high. Calculated virus concentrations below 10 4 are labelled as "borderline" (repeat measurement after 24-48h). Clinical endpoint are listed in table 3. The questionnaire comprised of 11 questions and the opportunity of free text. The questionnaire is available in the supplement 2 (S2). N=37 members of staff, who were involved in the operation of the POC instrument participated. 89% of respondents performed more than 10 measurements with the Liat in and outside of the current study. 73% performed more than 25 measurements and stated that they can integrate the POC testing very well into the treatment routine in the ED. More than 70% of respondents stated they were satisfied with the usability of the devices and 62% were satisfied with sample handling. In contrast 5% were unsatisfied with sample handling: holding the cartridges and pipettes simultaneously as well as the need to pipette beside the patient were points of criticism. In this current context 46% of the respondents were unsatisfied with hygienic conditions of sample processing. Main aspects for concerns were the location of the devices and the safety for employees and patients. 57% of respondents stated they were satisfied with display of results, 38% were undecided. Medical employees indicated that there should be greater ability to print the results directly at the POC instrument. Furthermore the results of POC testing had various effects. For one, they had an impact on interactions with the patients for 81% of the respondents, in addition, 86% of the respondents stated that the available results were valued by further departments/wards. The current study confirms (8, 9) the high accuracy of the Liat® SARS-CoV-2 POC PCR test and for the first time the feasibility of use in a large and busy ED with digital integration in the laboratory and hospital information systems (see figure 1) . The use of POC systems are always intended to shorten the turn-around-time (TAT). As in other studies, this could be shown here. Nevertheless, more important than the pure TAT is (1) the "time to actionable result" time of the attending physicians and (2) whether any important clinical action follows a POC test result. In our study we could clearly show that a majority of SARS-CoV-2 POC test results was available before an urgent care process has been started. Nevertheless, although the pure testing time of the instrument is 20min, the median time from admission to result was 102min, reflecting that there has been a delay in the implementation of the ED test strategy at the time of this study. As the test strategy is now standard in our institution and test capacities are sufficient, this time may be shorter in current routine care. The accuracy of the test results was 100%, although semiquantification revealed some differences (see table 2 ). The sensitivity of the POC instrument seems to be comparable to the reference standard, which is an advantage compared to other POC PCR systems, where 1-2% false negatives are reported (7) . Digital integration is a success factor under several aspects: (1) The digital order of the test including a standard label for the test tube ensures that the risk to mix up samples is minimized. (2) As the major incentive for the SARS-CoV-2 POC PCR is to speed up a complex pathway for emergency patients, it is mandatory that the test results are available for treating units including the operating theatre, intensive care and stroke units etc. In addition, tests need to be repeated and for this, it is most beneficial to have the results of the initial POC testing in the same system as the other laboratory test results. The use of high end POC devices in the ED requires trained staff, who are able to follow demanding test protocols as in this study due to hygiene rules as described in detail above (see also S1 for details). Thus, it is most important to assess the staff perspective on innovative POC test strategies. The staff was mostly satisfied with the technical aspects including sample handling and the ease of use of the instrument. A major concern, expressed by 46% of the participants were hygiene aspects of the test procedure. Although the test process follows strictly the regulations, many nurses feel uneasy with the step of pipetting a potential infectious sample although being sufficiently protected. We think that one solution of for this challenge could be the use of inactivating lysis buffer in the test tubes (11) . Currently, only transport media and saline are approved for the use with the instrument. Finally, the majority of participants valued that all admission processes and the interaction with patients and colleagues is supported by the POC PCR. The following future developments are necessary for the continuation of molecular POC testing in the ED. 1. Use of tubes with inactivating lysis buffer, to make the test safer for the users. Alternatively, laboratory workbenches needs to be integrated in the ED, which may be suitable some but no everywhere. 3. Future epidemiology of SARS-CoV-2 and other virus diseases will require a more differentiated test approach. Thus, in an actual very low incidence phase and no influenza at all, we would prefer to use a single SARS-CoV-2 test. In pediatrics the combination of SARS-CoV-2 and RSV would be interesting and at winter time the current triple test or even the addition of RSV would be beneficial. Finally, for future instrument development, a standardization of the PCR cycles with central laboratory instruments could help. Our study show that a fully digital integrated POC PCR test strategy improves fast and safe emergency processes in urgent patients under pandemic conditions in the ED. The POC-PCR testing in the emergency department is feasible and shows a very high diagnostic performance. The digital process integration is key for a high clinical impact in patients with acute indication for inpatient treatment. Table 3 . Clinical endpoints of all patients who were tested positive or negative for SARS-CoV-2 by POC-PCR; *, in n=6 patient an invalid result occurred on the POC instrument. Table 3 All patients Death % (n)* 10 (16) 25 (4) 7.2 (10) How emergency departments prepare for virus disease outbreaks like COVID-19. European journal of emergency medicine : official journal of the European Society for Emergency Medicine Which parameters support disposition decision in suspected COVID-19 cases in the emergency department (ED): a German clinical cohort study Rethinking Covid-19 Test Sensitivity -A Strategy for Containment Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals Overcoming the bottleneck to widespread testing: a rapid review of nucleic acid testing approaches for COVID-19 detection Point-of-care testing for influenza in a university emergency department: A prospective study. Influenza and other respiratory viruses Diagnostic Performance of a Rapid Point-of-care Test for SARS-CoV-2 in an Urban Emergency Department Setting Clinical Performance of the Point-of-Care cobas Liat for Detection of SARS-CoV-2 in 20 Minutes: a Multicenter Study Performance comparison of the Cobas® Liat® and Cepheid® GeneXpert® systems on SARS-CoV-2 detection in nasopharyngeal swab and posterior oropharyngeal saliva. Expert review of molecular diagnostics Diagnostic performance of a high-sensitive troponin T assay and a troponin T point of care assay in the clinical routine of an Emergency Department: A clinical cohort study Rapid and Safe Detection of SARS-CoV-2 and Influenza Virus RNA using Onsite qPCR Diagnostic Testing from Clinical Specimens Collected in Molecular Transport Medium. The journal of applied laboratory medicine The authors declare funding from Roche Molecular Systems for the submitted work. We acknowledge Clinical Research Unit (CRU) by Berlin Institute of Health (BIH), 10178Berlin, Germany for providing support regarding the use of the data management software (RedCap). We thank Dr. Victor Corman, Institute for Virology, Charité -Universitätsmedizin Berlin, providing the standard virus samples. This study was supported by a research grant from Roche Molecular Systems.